| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP and CCO | 6,813 | $1.96 | $13.4K | 55,584 | Apr 22, 2020 | Apr 24, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 19,893 | — | — | 62,397 | Apr 22, 2020 | Apr 24, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP and CCO | 2,593 | — | — | 2,592 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP and CCO | 2,353 | — | — | 21,014 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP and CCO | 8,464 | — | — | 8,463 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP and CCO | 2,593 | — | — | 23,607 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP and CCO | 2,353 | — | — | 0 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP and CCO | 22,853 | — | — | 54,924 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP and CCO | 22,853 | — | — | 45,707 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP and CCO | 8,464 | — | — | 32,071 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP and CCO | 12,420 | $2.77 | $34.4K | 42,504 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 211,690 | — | — | 211,690 | Feb 6, 2020 | Feb 10, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 70,560 | — | — | 70,560 | Feb 6, 2020 | Feb 10, 2020 ↗ | View → |